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ABSTRACT
Authors compared the incidence of chromosomal aberrations (CAs) of workers occupationally exposed to cytostatics (group EXP1) or 
anaesthetics (group EXP2) in relationship to polymorphism of GSTM1, GSTP1 and GSTT1 genes. The cytogenetic analysis for chromo-
somal aberrations frequency and for polymorphisms of genes the PCR and PCR-RFLP method were used. Statistically higher frequency 
of total CAs was detected in both exposed groups: group EXP1 1.90±1.34%; Mann-Whitney U-test, p=0.001; group EXP2 2.53±1.46%, 
p=0.0008) as compared to control (1.26±0.93%). In group EXP2 was detected statistically higher frequency of aberrations CSA-type as 
compared to CTA-type. In xenobiotic metabolizing genes for GST higher frequency of total CAs and constituent types chromatid-type 
aberrations (CTAs) and chromosome-type aberrations (CSAs) of genes GSTM1 and GSTT1 with null genotype was detected. Statistically 
significant difference was detected only in CSA-type of aberrations in GSTT1 gene. In gene GSTP1 was not detected any difference 
in frequency of aberrations in presence of the variant allele. Presented results point out importance of individual susceptibility in 
evaluation of genotoxic agents of anaesthetics or cytostatics.
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material. The most of mutagens are electrophilic agents, or 
can be metabolised by electrophilic intermediators. Connor 
(2006) reports that the skin is the first meeting point of 
antineoplastic agents´ contamination. After occupational 
exposure to cytostatics the increased frequency of chro-
mosomal aberrations, sister chromatid exchanges (SCE) 
or micronuclei (MN) in cells was described by many authors 
(Pilger et al., 2000; Burgaz et al., 2002). Musak et al. (2006) 
published the higher frequency of CAs in variant type of 
alleles in DNA repair genes XRCC1 exon 10 and XRCC3 
exon 7 and Mušák et al. (2008) detected statistically 
decrease of total CAs and CTAs in presence of variant allele. 
Testa et al. (2007) did not find out significant relationship 
between polymorphisms of genes for GST and higher fre-
quency of CAs. Angelini et al., (2008) detected important 
influence of genotype GSTT(–), in healthy individuals and 
after exposure to bleomycine (BLM). Rombaldi et al. (2009) 
analysed the genotoxicity using comet assay, and MN test 
as well as the level of oxidative stress. The exposed workers 
Introduction
The mutagenic, carcinogenic and cytotoxic effect of cyto-
statics (IARC 1996, Burgaz et al., 2002, Cavallo et al., 2005; 
Cavallo et al., 2007; Rekhadevi et al., 2007; Poljaková et 
al., 2008) and anaesthetics (IARC 1996, Jaloczynski 1999, 
Karpinski 2005) is permanently discussed. Workers in 
oncological units are occupationally excessively exposed to 
low doses of cytostatics and anaesthesiologists to volatile 
anaesthetics in the long term. Cytostatics genotoxicity 
is expressed especially by undirected damage of genetic 
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presented increased DNA damage levels by the comet assay 
as compared to the controls. The comet assay results have 
also shown significant positive correlation with the length 
of exposure and with the amount of consumed alcohol. 
The anaesthesiologists are excessively occupation-
ally exposed to volatile anaesthetics. The genotoxicity of 
desflurane was assessed by comet assay as extent of DNA 
fragmentation in peripheral human lymphocytes in vitro. 
The increased DNA migration was detected not only in cells 
exposed to halothane, but also to desflurane (Karpinski et 
al., 2005). There was not detected any increase of chromo-
somal aberrations´ number in patients exposed to anaes-
thetics during operation evidencing (Karahalil et al., 2005). 
Exposure to residues anaesthetics can increase the genetic 
damage comparable with damage caused by smoking 11–20 
cigarettes per day (Hoerauf et al., 1999). The increased 
incidence of CAs was detected by Rozgaj et al. (1999) in 
medical workers in operating rooms. Rozgaj and Kasuba 
(2000) and Rozgaj et al. (2001) assessed frequencies of 
CA, MN and SCE in anaesthesiologists, and found their 
increase particularly in females. Bilban et al. (2005) found 
out increased frequency of CAs (2.69%) in medical workers 
of operating and reaniming rooms, which was comparable 
to group of radiologists. The increase of DNA damage was 
detected as well by Chandrasekhar et al. (2006) using comet 
assay, MN test and peripheral blood lymphocytes analysis in 
buccal mucosa cells. His findings were not dependent on age 
and gender of observed persons.
The aim of study is detection of genotoxic effect´s 
biomarkers – total CAs, chromatid-type (CTAs) and 
chromosome-type (CSAs) of chromosomal aberrations, and 
evaluation of individual susceptibility of GSTM1, GSTP1 and 
GSTT1 genes in medical workers occupationally exposed to 
cytostatics or anaesthetics.
Material and methods
Seventy two workers (group EXP1) occupationally exposed 
to cytostatics and 76 workers (group EXP2) exposed to 
anaesthetics were analysed for frequency of chromo-
somal aberrations and polymorphisms of GST genes in 
comparison to control individuals. All of them completed 
anamnestic questionnaire about length and way of expo-
sure, job categorize, exogenous factors (smoke, drug usage, 
exposure to radiation, alcohol consumption and dietary) 
before blood collection and give an approving to be involved 
in the study. Group EXP1 represented workers from spe-
cialized oncologic departments from three hospitals in 
north part middle Slovakia region – Faculty Hospital in 
Martin (n=28), Central Military Hospital in Ružomberok 
(n=31) and Hospital with Polyclinic in Trstená (n=13). All 
of workers were regularly in contact with cytostatics that 
dilute and apply to patients. By job grade they are classi-
fied as nurses (80.55%) and physicians. Both groups consist 
predominantly of females (90.28%). Smokers presented 
26.39%. Group EXP2 consists of 76 workers from Faculty 
Hospital in Martin (n=60) and Central Military Hospital in 
Ružomberok (n=16). All of workers were regularly exposed 
to volatile anaesthetics. By job grade they are classified as 
anaesthesiologic physicians (53.95%) and nurses (46.05%). 
They participated in application of volatile anaesthetics 
during surgical interventions in complete anaesthesia in 
operating rooms. Groups consist predominantly of female 
persons (80.26%). Smokers presented 30.26%. Control 
group consisted of workers of Medical Faculty Hospital in 
Martin and workers from Biotika factory in Martin. They 
were not exposed to any genotoxic agents. Characteristics 
of both exposed groups and control are present in Table 1. 
We microscopically analysed 100 mitoses per person and 
evaluated the frequency of total chromosomal CAs, and 
constituent types: CTA-type and CSA-type of aberra-
tions. Methodology of cytogenetic analysis was performed 
according to AHEM (2007). Polymorphisms of GST genes 
were performed by PCR methods. Gene GSTM1 prim-
ers – F (forward): 5’-CTG CCC TAC TTG ATT GAT G-3’; 
R (reverse): 5’-CTG GAT TGT AGC AGA TCA TGC-3’; 
size of fragments: 1) normal homozygote or heterozygote 
(GSTM1-plus) – 275  bp (GSTM1) and 175  bp (GSTM2), 2) 
variant homozygote (GSTM-null) – GSTM1 product not 
form and 175 bp (GSTM2). Genes GSTP1 and GSTT1 prim-
ers GSTP1-F (forward): 5´- TCC TTC CAC GCA CAT CCT 
CT-3´; GSTP1-R (reverse): 5´-AGC CCC TTT CTT TGT TCA 
GC-3´; GSTT1-F (forward): 5´-TTC CTT ACT GGT CCT 
CAC ATC TC-3´; GSTT1-R (reverse): TCA CCG GAT CAT 
GGC CAG CA; size of fragments 1) normal homozygote or 
heterozygote (GSTT1-plus) – 480 bp; 2) variant homozygote 
(GSTM-null) – product not form; restriction enzyme 
BsmAI, size of fragments: 1) normal homozygote (Ile105Ile) 
– 294 bp, 2) heterozygote (Ile105Val) – 294+234+60 bp, 3) 
variant homozygote (Val105Val) – 234+60 bp. All principles 
for protection personnel data, for health care are accepted in 
this paper. Peripheral blood sampling was realized within the 
specialised medical examinations. Statistical analysis was 
performed by program Statgraphics, version 7 (Manugistics, 
Cambridge, MA). There was used nonparametric Mann-
Whitney U-test for testing differences between groups 
and analysis of variance (ANOVA) for testing relationships 
between biomarkers and genotype. The values in tables are 
as average ± standard deviation (S.D.) 
Results
We detected statistically higher frequency of total chro-
mosomal aberrations (CAs) in group EXP1 (1.90±1.34%; 
p=0.001) and group EXP2 (2.53±1.46%; p=0.0008) in 
comparison to control (1.26±0.93%). In group EXP1 we 
did not detect any difference between CTA-type and 
CSA-type – 0.92±1.04% vs. 0.98±1.17%; on the contrary 
in group EXP2 we detected statistically higher frequency 
o f  a b e r r a t i o n s  C S A - t y p e  i n  c o m p a r i s o n  t o  C T A - t y p e  
(1.92±1.38% vs. 0.61±0.83%; p=0.0009). Evaluating the role 
of polymorphisms of GSTM1 gene we did not observed 
significant difference in group EXP1, but in group EXP2 
we detected the increase of total CAs, CTA-type and CSA-
type in null variant as compared to plus variant (Figures 1, 
2 and 3). Evaluating of GSTP1 gene polymorphisms we 192
Ľ. Mušák, E. Halašová, T. Matáková, L. Letková, L. Vodičková, J. Buchancová, H. Hudečková, O. Osina, P. Souček, P. Vodička
Comparison of chromosomal aberrations frequency and polymorphism of GSTs genes 
ISSN: 1337-6853 (print version) | 1337-9569 (electronic version)
did not detect any differences in presence of variant allele 
(Figures 4, 5 and 6). Evaluation of GSTT1 gene showed 
slightly increase of total CAs, and CTA-type in group EXP1, 
and higher (statistically not significant) frequency of total 
CAs as well as significant difference (p=0.05) in null vari-
ant as compared to plus variant of CSA-type in group EXP2 
(Figures 7, 8 and 9). 
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Figure 1. Polymorphisms of GSTM1 gene in exposed group to 
cytostatics.
Figure 4. Polymorphisms of GSTP1 gene in exposed group to 
cytostatics.
Figure 2. Polymorphisms of GSTM1 gene in exposed group to 
anaesthetics.
Figure 5. Polymorphisms of GSTP1 gene in exposed group to 
anaesthetics.
Figure 3. Polymorphisms of GSTM1 gene in control group. Figure 6. Polymorphisms of GSTP1 gene in control group.
Discussion
Cytostatics are mutagenic and carcinogenic agents (Vorlíček 
et al., 2000). They cause variously DNA damage. Burgaz et 
al. (2002) and Cavallo et al. (2005) examined workers in 
contact with cytostatics (nurses and pharmaceutical work-
ers that prepared, diluted or applied cytostatics; orderlies in 193
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contact with bed sheets and possibly excrements of treated 
patients). They both observed the higher frequency of CAs 
and MN in buccal mucosa cells in exposed workers. Burgaz 
et al. (2002) detected 2.5-time higher frequency of CAs in 
exposed persons. 
Anaesthesiology workers are notable exposed to volatile 
anaesthetics during occupational activity. In many papers is 
presented the increase of aberrant cells in operating rooms 
workers (Rozgaj et al., 1999; Rozgaj et al., 2001; Natarajan, 
2002). Our findings are in accordance with previously men-
tioned; we detected statistically higher frequency of total CAs 
in group EXP1 and group EXP2 as well. Numerous authors 
determined in their explorations that the increased risk to 
exposure of genotoxic agents is related with inconsistent 
observance of safety regulations. The higher exposures to 
cytostatics were observed at workplaces, where the person-
nel was not adequately informed about risk associated with 
this job (Connor, 2006; Fransman et al., 2007a; Fransman et 
al., 2007b ). The increased number of chromosomal aberra-
tions in group EXP2 can be caused by unsuitable conditions 
of employment (i.e. not effective or inadequately effective 
air circulation, operating rooms without air-conditioning) 
in comparison to control. The extensive research of employ-
ment conditions showed, that in operating rooms with 
10–12 multiple air circulation only, can be the concentra-
tion of halothane decreased to 50–80 mg.m–3 (Wiesner et 
al., 2001). The role of gene-environmental interactions has 
been frequently discussed for last years and the research 
results have pointed on their relation to diseases formation 
in some individuals. It is believed that this interaction can 
be influenced by gene polymorphism (Horváthová, 2008). 
For the determination of CAs frequency in human lympho-
cytes we analysed specific polymorphisms of genes partici-
pated in metabolism of genotoxic agents. We analysed the 
polymorphism of GSTs genes. In gene GSTM1 and GSTT1 
we detected higher frequency of total CAs and constituent 
types i.e. CTA-type and CSA-type in both exposed groups. 
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Figure 7. Polymorphisms of GSTT1 gene in exposed group to 
cytostatics.
Figure 8. Polymorphisms of GSTT1 gene in exposed group to 
anaesthetics.
Figure 9. Polymorphisms of GSTT1 gene in control group.
Table 1. Characteristics of exposed groups and control.
EXP1 EXP2 Control
Number 72 76 76
Age (years±S.D.) 41.19±8.95 36.89±8.75 35.99±7.73
Exposure (years±S.D.) 11.31±8.98 11.75±9.35
Sex (N) M/F 7 / 65 15 / 61 16 / 60
Smoking (N) S/NS 19 / 53 23 / 53 15 / 61
Job (N) physician/nurse 14 / 58 41 / 35 20 / 56
Table 2. Chromosomal aberrations expressed percentage in exposed 
groups and control.
Number of 
mitosis (N)
Number of 
Ab.c. (N)
Percentage of 
CAs (%) ± S.D.
EXP1 – cytostatics 7200 137 1.90±1.34***
EXP2 – anaesthetics 7600 192 2.53±1.46***
Control 7600 96 1.26±0.93
*** p=0.001 (EXP1); *** p=0.0008 (EXP2) - total CAs exposed vs. control194
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Scarpato et al., (1997) detected the higher frequency of CAs 
in smokers in absence of allele GSTM1 gene (GSTM1 null 
variant). The absence of gene for GSTM1 and GSTT1 point 
out the higher frequency of CAs in comparison with pres-
ence GSTM1 gene and absence GSTT1 gene in drivers of 
busse (Norppa et al., 2006). 
Presented results finger on importance of individual 
susceptibility in assessment of genotoxic effects, in cases, 
the concentration of genotoxic agents usually doesn’t exceed 
the occupational exposure limits.
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